VHIO Develops VIGex: Pan-Cancer Platform for Personalized Immunotherapy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A pan-cancer platform to help guide patient selection for personalized immunotherapy medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a.
The 2022 awards see work with climate change being acknowledged and a wife and husband team making the list. COMPANION (AC) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA Dr Alan Simon FINKEL AO, South Yarra VIC 3141 For eminent service to science, to national energy innovation and research infrastructure capability, to climate change and COVID-19…
NephroSant Secures Medicare Coverage for QSant, the First Urine-based Kidney Transplant Rejection Test, and Plans 2022 Launch prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.